Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancer
Thomais Vlachogianni,1 Konstantinos Fiotakis,1 Spyridon Loridas,1 Stamatis Perdicaris,2 Athanasios Valavanidis1 1Department of Chemistry, Free Radicals Research Group, 2Faculty of Pharmacy, Department of Pharmacognosy and Natural Product Chemistry, University of Athens, Athens, Greece Abstract: Engi...
Guardado en:
Autores principales: | Vlachogianni T, Fiotakis K, Loridas S, Perdicaris S, Valavanidis A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8f1b91a9a596470b9c4957ee77b70bd2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Profile of bavituximab and its potential in the treatment of non-small-cell lung cancer
por: Stasi I, et al.
Publicado: (2014) -
Clinical potential of nintedanib for the second-line treatment of advanced non-small-cell lung cancer: current evidence
por: Rothschild SI
Publicado: (2014) -
Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancer
por: Mark A. Socinski, et al.
Publicado: (2021) -
Lung cancer in women
por: Barrera-Rodriguez R, et al.
Publicado: (2012) -
Hepatoid Adenocarcinoma of the Lung
por: Meihui Li, et al.
Publicado: (2021)